Infant T-cell acute lymphoblastic leukaemia with t(6;7) (TCRB-MYB) translocation.


Journal

British journal of haematology
ISSN: 1365-2141
Titre abrégé: Br J Haematol
Pays: England
ID NLM: 0372544

Informations de publication

Date de publication:
08 2021
Historique:
revised: 05 05 2021
received: 07 04 2021
accepted: 11 05 2021
pubmed: 3 7 2021
medline: 15 12 2021
entrez: 2 7 2021
Statut: ppublish

Résumé

T-ALL is rare in infancy with only 10 (1.5%) of 651 patients of that subtype in the Interfant-06 infant ALL trial. We report 3 cases of t(6;7) (TCR/MYB) infant T-cell Acute Lymphoblastic Leukaemia who appear to have a distinct clinical presentation with CNS disease and refractory disease or late relapse.

Identifiants

pubmed: 34212378
doi: 10.1111/bjh.17609
doi:

Substances chimiques

MYB protein, human 0
Proto-Oncogene Proteins c-myb 0
Receptors, Antigen, T-Cell, alpha-beta 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

613-616

Informations de copyright

© 2021 British Society for Haematology and John Wiley & Sons Ltd.

Références

Pieters R, Lorenzo P, Ancliff P, Aversa LA, Brethon B, Biondi A, et al. Outcome of infants younger than 1 year with acute lymphoblastic leukaemia treated with Interfant-06 protocol: results from an international phase III randomised study. J Clin Oncol. 2019;37, 2246-56.
Mansur M, Delft F, Colman S, Furness CL, Gibson J, Emerenciano M, et al. Distinctive genotype in infants with T- cell acute lymphoblastic leukaemia. British J Haematol. 2015;171:574-84
Clappier E, Cuccuini W, Kalota A, Crinquette A, Cayuela JM, Dik WA, et al. The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukaemia (T-ALL), the translocation defining a new T-ALL subtype in very young children. Blood. 2007;110:1251-61.
Homminga I, Pieters R, Langerak A, de Rooi J, Stubbs A, Verstegen M, et al. Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. Cancer Cell. 2011;19:484-97.

Auteurs

Pemantah Sandheeah Ramdeny (PS)

Department of Haematology, Great Ormond Street Hospital, London, UK.

Khushnuma Mullanfroze (K)

Department of Haematology, Great Ormond Street Hospital, London, UK.

Paola de Lorenzo (P)

Center of Bioinformatics, Biostatistics and Bioimaging, University of Milano-Bicocca, Monza, Italy.
Pediatrics, School of Medicine and Surgery, University of Milano-Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, Italy.

Maria Grazia Valsecchi (M)

Center of Bioinformatics, Biostatistics and Bioimaging, University of Milano-Bicocca, Monza, Italy.

Jules Meijerink (J)

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.

Rob Pieters (R)

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.

Andre Baruchel (A)

Université de Paris and Hôpital Universitaire Robert Debré(APHP), Paris, France.

Ajay Vora (A)

Department of Haematology, Great Ormond Street Hospital, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH